| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/18/2013 | EP2638897A1 Method for Manufacturing medicinal Compounds containing Dabigatran |
| 09/18/2013 | EP2638894A1 Pharmaceutical composition containing phospholipid |
| 09/18/2013 | EP2637701A2 Gas-filled microbubbles and systems for gas delivery |
| 09/18/2013 | EP2637700A2 Compositions and methods for the prevention and treatment of cancer |
| 09/18/2013 | EP2637699A1 Double-acylated glp-1 derivatives with a linker |
| 09/18/2013 | EP2637698A1 Double-acylated glp-1 derivatives |
| 09/18/2013 | EP2637697A2 Modified immune-modulating particles |
| 09/18/2013 | EP2637696A2 Sustained release compositions |
| 09/18/2013 | EP2637695A1 Olmesartan formulations |
| 09/18/2013 | EP2637692A2 Antibodies to tumor endothelial marker 8 |
| 09/18/2013 | EP2637642A1 Liquid pharmaceutical composition for the treatment of a posterior eye disease |
| 09/18/2013 | CN103313732A Gel sheet comprising lipidic peptide type gelling agent and polymeric compound |
| 09/18/2013 | CN103313730A Compositions of a peptide-based system for cell-specific targeting |
| 09/18/2013 | CN103313729A O/W-emulsions comprising semifluorinated alkanes |
| 09/18/2013 | CN103313724A Compounds and methods |
| 09/18/2013 | CN103313710A Patch |
| 09/18/2013 | CN103313706A Controlled release mucoadhesive systems |
| 09/18/2013 | CN103313703A Decay-type nuclear particle for pharmaceutical formulation |
| 09/18/2013 | CN103313701A Pharmaceutical compositions of pyridinium and quinolinium derivatives |
| 09/18/2013 | CN103313700A Topical gel composition |
| 09/18/2013 | CN103304804A Polyethylene glycol-polyamide-amine-polyamino acid linear-dendritic block polymer and preparation method thereof |
| 09/18/2013 | CN103304802A Acid-sensing amphipathic segmented copolymer as well as preparation method and application thereof |
| 09/18/2013 | CN103304733A Preparation method of degradable environmental sensitive polymer nano hydrogel and application |
| 09/18/2013 | CN103304687A Preparation of full-6-(3'S-tetrahydroisoquinolin-3'-formylamino)-6-deoxy-beta-cyclodextrin and application |
| 09/18/2013 | CN103304669A Humanization tumor immune cell cytokines TNTIL2 as well as preparation method and application thereof |
| 09/18/2013 | CN103304637A Cell permeable peptide hPP3 and usage thereof |
| 09/18/2013 | CN103304569A Erlotinib-phthalocyanine conjugate and preparation method thereof |
| 09/18/2013 | CN103304445A Cation polyglycerol ester lipid and synthetic method and application thereof |
| 09/18/2013 | CN103304417A Preparation method and application of amphiphatic copolymer modified chitosan compound |
| 09/18/2013 | CN103301760A Dissolving method of L-tetrahydropalmatine, L-tetrahydropalmatine solution and application of L-tetrahydropalmatine solution |
| 09/18/2013 | CN103301482A Amphipathy tri-block polypeptide ICG (Indocyanine Green) loaded micelle and preparation method thereof |
| 09/18/2013 | CN103301481A Target nucleic acid drug delivery system and application thereof |
| 09/18/2013 | CN103301473A Cis-platinum and gold nanoparticle hollow sphere shell carrier compound with light-operated releasing function and preparation method |
| 09/18/2013 | CN103301472A Amphiphilic polysaccharide-anti-tumor medicament conjugate capable of releasing medicines specifically at lesion site of living body, as well as preparation method and application of medicinal composition of amphiphilic polysaccharide-anti-tumor medicament conjugate |
| 09/18/2013 | CN103301471A Lyophilized vaccine for porcine rotavirus (PRV) |
| 09/18/2013 | CN103301470A Plant sterol glycol chitosan targeting vector, preparation method and application thereof |
| 09/18/2013 | CN103301469A Preparation method of sephadex microsphere with smooth surfaces |
| 09/18/2013 | CN103301468A High-content luteolin composition |
| 09/18/2013 | CN103301467A Stable taste-masking ambroxol hydrochloride compound and preparation method thereof |
| 09/18/2013 | CN103301466A Hydroprednisone injection composition and preparation method thereof |
| 09/18/2013 | CN103301465A Preparation and applications of near-infrared light drug controlled release system taking silver/oxidized graphene composite nanoparticle as carrier |
| 09/18/2013 | CN103301461A Long-acting injectable preparation, preparation method and application thereof |
| 09/18/2013 | CN103301460A Ferroferric oxide loaded compound micropowder and application thereof |
| 09/18/2013 | CN103301454A Lyophilized vaccine for classical swine fever |
| 09/18/2013 | CN103301453A Freeze-dried vaccine for porcine reproductive and respiratory syndrome and preparation method thereof |
| 09/18/2013 | CN103301452A Lyophilized vaccine for swine encephalitis B and preparation method thereof |
| 09/18/2013 | CN103301451A Brucellin live vaccine freezing-drying protecting agent for intradermal injection |
| 09/18/2013 | CN103301450A Plague live vaccine freezing-drying protecting agent for percutaneous scarification |
| 09/18/2013 | CN103301446A Affinity adsorption material for treating hyperbilirubinemia and preparation method thereof |
| 09/18/2013 | CN103301445A Calcitonin long-acting slow-release microspheres and preparation method and combination thereof |
| 09/18/2013 | CN103301295A Kangfu anti-inflammatory vaginal expansion suppository as well as preparation method and detection method thereof |
| 09/18/2013 | CN103301251A Traditional Chinese medicine composition for preventing and cow treating mastitis |
| 09/18/2013 | CN103301204A Compound fructus forsythiae-radix bupleuri oil nanoemulsion and preparation method |
| 09/18/2013 | CN103301194A Preparation technology of cold-pressed perilla seed oil capsule and its product |
| 09/18/2013 | CN103301165A Grinding method and application of cordyceps sinensis |
| 09/18/2013 | CN103301144A Antibiotic premixing agent for inhibiting porcine reproductive and respiratory syndrome virus for livestock and preparation method thereof |
| 09/18/2013 | CN103301135A Azasetron composition for injection |
| 09/18/2013 | CN103301128A Esomeprazole sodium composition for injection |
| 09/18/2013 | CN103301127A Lansoprazole composition for injection |
| 09/18/2013 | CN103301125A Levorotatory pantoprazole sodium composition for injection |
| 09/18/2013 | CN103301121A Oral candesartan cilexetil solid preparation and preparation method thereof |
| 09/18/2013 | CN103301120A Preparation method of compound amino acid injection |
| 09/18/2013 | CN103301119A Edaravone composition for injection |
| 09/18/2013 | CN103301101A Novel 2-(2-fluorine-4biphenyl)-propionic acid pharmaceutical composition |
| 09/18/2013 | CN103301098A Compound chlorhexidine vaginal expansion suppository as well as preparation method and detection method thereof |
| 09/18/2013 | CN103301095A Porous composite medicine-loaded composition for improving oral absorption for probucol, and preparation method of porous composite medicine-loaded composition |
| 09/18/2013 | CN103301093A Testosterone transdermal absorbent patch |
| 09/18/2013 | CN103301092A Polymer micro-needle array chip, and preparation method and application thereof |
| 09/18/2013 | CN103301091A Gastrodin double-pulse drug-release preparation |
| 09/18/2013 | CN103301090A Preparation method of genistein targeted nanometer particle |
| 09/18/2013 | CN103301089A Famciclovir capsule preparation and preparation method thereof |
| 09/18/2013 | CN103301087A Production process of enteric gelatin hollow capsules |
| 09/18/2013 | CN103301086A Plant cellulose hard empty capsule preparation method |
| 09/18/2013 | CN103301085A Aquatic animal medicine feeding capsule and preparation method thereof |
| 09/18/2013 | CN103301083A Nifedipine slow release tablet and preparation method thereof |
| 09/18/2013 | CN103301080A Moxifloxacin hydrochloride-containing pharmaceutical composition and preparation method thereof |
| 09/18/2013 | CN103301079A Capecitabine pharmaceutical composition and preparation method thereof |
| 09/18/2013 | CN103301078A Lyophilized preparation of D-sodium lansoprazole, and preparation method thereof |
| 09/18/2013 | CN103301077A Esomeprazole sodium composition for injection and preparation method thereof |
| 09/18/2013 | CN103301075A Suspension granules for cefixime composition and preparation method thereof |
| 09/18/2013 | CN103301073A Methotrexate targeted nanoparticle sustained-release preparation and preparation method thereof |
| 09/18/2013 | CN103301072A Preparation method of sorafenib nanoparticles |
| 09/18/2013 | CN103301071A Stable entecavir sugarless granules and preparation method thereof |
| 09/18/2013 | CN103301069A Levofloxacin granule and preparation method thereof |
| 09/18/2013 | CN103301068A Cefixime dry suspension and preparation method thereof |
| 09/18/2013 | CN103301067A Solid dispersion for improving absorbing property and preparation method thereof |
| 09/18/2013 | CN103301066A Solid dispersion for improving absorbing property and preparation method thereof |
| 09/18/2013 | CN103301062A Medium and long-chain lipid emulsion injection preparation method |
| 09/18/2013 | CN103301061A Docetaxel freeze-dried microemulsion preparation and preparation method thereof |
| 09/18/2013 | CN103301058A Composition for teriparatide injection, and preparation method and preparation thereof |
| 09/18/2013 | CN103301057A Tilmicosin injection capable of improving low-temperature freezing resistance and preparation method of tilmicosin injection |
| 09/18/2013 | CN103300278A Composition comprising imidazole peptide and quercetin glycoside |
| 09/18/2013 | CN102920668B Pantoprazole sodium freeze-dried powder injection and preparation method thereof |
| 09/18/2013 | CN102908359B Composite calcium carbonate/vitamin D3 granules for children and preparation method thereof |
| 09/18/2013 | CN102860988B Chymotrypsin composition freeze-dried powder and preparation method thereof |
| 09/18/2013 | CN102813932B Duck viral hepatitis egg yolk antibody cryoprotectant |
| 09/18/2013 | CN102716494B Nucleic acid medicine loading system for targeted therapy and preparation method of nucleic acid medicine loading system |
| 09/18/2013 | CN102676563B Method for preparing human serum albumin-human parathyroid hormone |
| 09/18/2013 | CN102671199B Dissolving agent capable of dissolving diclazuril and ethopabate simultaneously and anticoccidial medicinal composition |
| 09/18/2013 | CN102670524B Pantoprazole sodium freeze-dried preparation for injection and preparation method thereof |